Merck & Co., Inc. (MRK) News Today $74.68 +1.21 (+1.65%) Closing price 05/15/2025 03:59 PM EasternExtended Trading$75.17 +0.48 (+0.65%) As of 07:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Merck & Co., Inc. (NYSE:MRK) Stock Holdings Decreased by Quadcap Wealth Management LLCQuadcap Wealth Management LLC lowered its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 12.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 24,458 shares of the company's stock after selling 3,447 shares during the period. Quadcap Wealth Management LLMay 16 at 7:00 AM | marketbeat.comNomura Holdings Inc. Has $13.54 Million Stake in Merck & Co., Inc. (NYSE:MRK)Nomura Holdings Inc. trimmed its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 53.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 136,100 shares of the company's stock after sellingMay 16 at 6:10 AM | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Stock Holdings in Merck & Co., Inc. (NYSE:MRK)MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 13.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 298,752 shares of the company's stock after buying an additional 36,085 sMay 16 at 5:24 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Stock Price Down 2.5% - Here's WhyMerck & Co., Inc. (NYSE:MRK) Shares Down 2.5% - Here's What HappenedMay 15 at 2:45 PM | marketbeat.comMerck & Co., Inc. (MRK): One of the Best Dividend Growth Stocks with High YieldsMay 15 at 12:12 PM | insidermonkey.comQuantinno Capital Management LP Grows Stock Position in Merck & Co., Inc. (NYSE:MRK)Quantinno Capital Management LP boosted its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 8.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 233,548 shares of the company's stock aftMay 15 at 8:41 AM | marketbeat.comMerck & Co., Inc.'s (MRK) Neutral Rating Reiterated at CitigroupCitigroup reiterated a "neutral" rating and issued a $84.00 price objective (down previously from $115.00) on shares of Merck & Co., Inc. in a report on Wednesday.May 15 at 8:37 AM | marketbeat.comPathstone Holdings LLC Sells 8,066 Shares of Merck & Co., Inc. (NYSE:MRK)Pathstone Holdings LLC lessened its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 520,259 shares of the company's stock after selling 8,066 shares during the quarter. Pathstone HoldingMay 15 at 8:31 AM | marketbeat.comMufg Securities Americas Inc. Purchases New Stake in Merck & Co., Inc. (NYSE:MRK)Mufg Securities Americas Inc. purchased a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 37,342 shares of the company's stock, valued atMay 15 at 8:10 AM | marketbeat.comNissay Asset Management Corp Japan ADV Raises Position in Merck & Co., Inc. (NYSE:MRK)Nissay Asset Management Corp Japan ADV raised its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 325,319 shares of the company's stock after buying an additionalMay 15 at 7:34 AM | marketbeat.comMerck & Co., Inc. Q1 Earnings TranscriptMay 15 at 7:08 AM | marketbeat.comNorthRock Partners LLC Boosts Stock Position in Merck & Co., Inc. (NYSE:MRK)NorthRock Partners LLC lifted its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 96.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,142 shares of the company's stock after buyingMay 15 at 6:50 AM | marketbeat.comMerck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All ComersMay 15 at 6:45 AM | businesswire.comNuveen Asset Management LLC Has $1.20 Billion Stock Position in Merck & Co., Inc. (NYSE:MRK)Nuveen Asset Management LLC lessened its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 8.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,085,520 shares of the company's stock after selling 1,184,7May 15 at 6:34 AM | marketbeat.com21,542 Shares in Merck & Co., Inc. (NYSE:MRK) Purchased by Numerai GP LLCNumerai GP LLC acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 21,542 shares of the company's stock, valued at approximately $2,143,000. A numbeMay 15 at 6:27 AM | marketbeat.comFDA Approves Merck's WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)May 14 at 6:08 PM | businesswire.comMerck & Co., Inc. (MRK) BofA Securities 2025 Healthcare Conference (Transcript)May 14 at 5:11 PM | seekingalpha.comMerck & Co., Inc. (NYSE:MRK) Stock Price Down 3.4% - What's Next?Merck & Co., Inc. (NYSE:MRK) Shares Down 3.4% - Time to Sell?May 14 at 3:40 PM | marketbeat.comUS FDA expands use of Merck's cancer drug for adrenal gland tumorsMay 14 at 1:29 PM | reuters.comUS FDA expands use of Merck's cancer drug for adrenal gland tumorsMay 14 at 1:29 PM | reuters.comMerck & Co., Inc. (NYSE:MRK) Shares Gap Down - Here's WhyMerck & Co., Inc. (NYSE:MRK) Shares Gap Down - Here's WhyMay 14 at 1:06 PM | marketbeat.comPharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.May 14 at 9:55 AM | barrons.comGermany's Merck drops China surcharge on orders after US-China tariff dealMay 14 at 8:46 AM | reuters.comOMERS ADMINISTRATION Corp Raises Stock Holdings in Merck & Co., Inc. (NYSE:MRK)OMERS ADMINISTRATION Corp grew its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 15.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 230,181 shares of the company's stock after acquiring an additional 31,6May 14 at 7:55 AM | marketbeat.comOrbimed Advisors LLC Has $82.56 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)Orbimed Advisors LLC lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 36.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 829,900 shares of the company's stock after seMay 14 at 7:44 AM | marketbeat.comObermeyer Wealth Partners Has $16.45 Million Holdings in Merck & Co., Inc. (NYSE:MRK)Obermeyer Wealth Partners lessened its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 8.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 165,381 shares of the company's stock after selling 15,386 shares during the qMay 14 at 7:41 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Morse Asset Management IncMorse Asset Management Inc trimmed its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 19.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,204 shares of the company's stock after selling 5,200 shMay 14 at 6:57 AM | marketbeat.comNew England Asset Management Inc. Lowers Stake in Merck & Co., Inc. (NYSE:MRK)New England Asset Management Inc. lowered its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 16.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 31,280 shares of the company'sMay 14 at 6:39 AM | marketbeat.comMerck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to BuyMay 14 at 2:47 AM | finance.yahoo.comRep. Bruce Westerman Sells Off Shares of Merck & Co., Inc. (NYSE:MRK)Representative Bruce Westerman (R-Arkansas) recently sold shares of Merck & Co., Inc. (NYSE:MRK). In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Merck & Co., Inc. stock on April 21st. The trade occurred in the Representative's "FISHEMay 14 at 2:03 AM | marketbeat.comIs Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?May 13 at 8:54 PM | msn.comMerck & Co., Inc. (NYSE:MRK) Trading Up 4.1% - Still a Buy?Merck & Co., Inc. (NYSE:MRK) Shares Up 4.1% - Still a Buy?May 13 at 4:53 PM | marketbeat.comMJP Associates Inc. ADV Purchases 6,479 Shares of Merck & Co., Inc. (NYSE:MRK)MJP Associates Inc. ADV raised its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 53.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 18,635 shares of the company's stock after buying an additiMay 13 at 7:34 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Bought by Lazard Asset Management LLCLazard Asset Management LLC lifted its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 438.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,408,939 shares of the company's stock after acquiring an additionalMay 13 at 7:20 AM | marketbeat.comLeigh Baldwin & CO. LLC Takes $207.36 Million Position in Merck & Co., Inc. (NYSE:MRK)Leigh Baldwin & CO. LLC acquired a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 2,073,597 shares of the company's stock, valued at approximately $207,36May 13 at 7:15 AM | marketbeat.comLetko Brosseau & Associates Inc. Purchases 3,425 Shares of Merck & Co., Inc. (NYSE:MRK)Letko Brosseau & Associates Inc. raised its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 235,734 shares of the company's stock after buying an additional 3,425 sMay 13 at 7:14 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by London Co. of VirginiaLondon Co. of Virginia cut its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 6.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,167,012 shares of the company's stock after selling 161,330 shares during the period. London Co. of Virginia ownedMay 13 at 6:49 AM | marketbeat.comResearch on Novel Treatment Approaches and Scientific Advances From Merck's Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025May 13 at 6:45 AM | businesswire.comLionshead Wealth Management LLC Makes New $536,000 Investment in Merck & Co., Inc. (NYSE:MRK)Lionshead Wealth Management LLC acquired a new position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 5,342 shares of the company's stock, valued at approximatelMay 13 at 6:18 AM | marketbeat.comInvestment Management Corp of Ontario Sells 47,839 Shares of Merck & Co., Inc. (NYSE:MRK)Investment Management Corp of Ontario lessened its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 28.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 120,214 shares oMay 12, 2025 | marketbeat.comInvestor s Fiduciary Advisor Network LLC Invests $3.40 Million in Merck & Co., Inc. (NYSE:MRK)Investor s Fiduciary Advisor Network LLC purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 34,146 shares of the company'sMay 12, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Reduces Stock Position in Merck & Co., Inc. (NYSE:MRK)Jacobs Levy Equity Management Inc. decreased its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 28.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,377,437 shares of the company's stock afMay 12, 2025 | marketbeat.comJanus Henderson Group PLC Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK)Janus Henderson Group PLC lessened its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 33.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,864,505 shares of the company's stock after selling 2,90May 12, 2025 | marketbeat.comK2 Principal Fund L.P. Buys Shares of 13,032 Merck & Co., Inc. (NYSE:MRK)K2 Principal Fund L.P. bought a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 13,032 shares of the company's stock, valued at approximately $1,296,0May 12, 2025 | marketbeat.comKahn Brothers Group Inc. Has $50.63 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK)Kahn Brothers Group Inc. lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 508,908 shares of the companMay 12, 2025 | marketbeat.comHumankind Investments LLC Boosts Stock Position in Merck & Co., Inc. (NYSE:MRK)Humankind Investments LLC increased its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 22.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 28,909 shares of the company's stock after acquiring an additional 5,248 sharesMay 12, 2025 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Acquired Rep. Robert Bresnahan, Jr.May 12, 2025 | americanbankingnews.comJeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior PrincipalMay 12, 2025 | globenewswire.comRep. Robert Bresnahan, Jr. Purchases Shares of Merck & Co., Inc. (NYSE:MRK)Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Merck & Co., Inc. (NYSE:MRK). In a filing disclosed on May 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in Merck & Co., Inc. stock on April 8th. The trade occurred in the RepresentMay 11, 2025 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Sets New 1-Year Low - Here's WhyMerck & Co., Inc. (NYSE:MRK) Reaches New 12-Month Low - What's Next?May 11, 2025 | marketbeat.com Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address MRK Media Mentions By Week MRK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼1.210.79▲Average Medical News Sentiment MRK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼7348▲MRK Articles Average Week Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Eli Lilly and Company News Johnson & Johnson News AbbVie News Pfizer News Bristol-Myers Squibb News Zoetis News Royalty Pharma News Corcept Therapeutics News Jazz Pharmaceuticals News Perrigo News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRK) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Big Swings in Crypto Right Now — and Bigger Moves Could Be Coming That kind of whiplash might scare some fo...Crypto 101 Media | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredCan This System Really Predict Stocks to the Day?Imagine foreseeing a 30% stock jump — to the day — weeks before it happens. Introducing a new way to predict t...InvestorPlace | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck & Co., Inc. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.